However, in contrast to highly susceptible cells in which SARS-CoV-2 N was expressed at high amounts and was homogenously distributed at late stages of infection [20], we observed a puncate distribution pattern of N in the IFN-treated ECs, suggesting that viral replication in theses cells was slightly impaired. The gene discussed is IFNA1; the disease is infection.